Skip to main content
Title Pub Year Author Sort ascending SearchLink
Smoking-cessation prevalence among U.S. smokers of menthol versus non-menthol cigarettes 2011 Center for Tobacco Surveillance and Evaluation Research, School of Public Health, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA. delnevo@umdnj.edu
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
American Journal of Preventive Medicine
Periodical, Abbrev.
Am.J.Prev.Med.
Pub Date Free Form
Oct
Volume
41
Issue
4
Start Page
357
Other Pages
365
Notes
CI: Copyright (c) 2011; JID: 8704773; 0 (Flavoring Agents); 1490-04-6 (Menthol); 2011/06/10 [received]; 2011/06/27 [revised]; 2011/06/28 [accepted]; ppublish
Place of Publication
Netherlands
ISSN/ISBN
1873-2607; 0749-3797
Accession Number
PMID: 21961462
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; IM
DOI
10.1016/j.amepre.2011.06.039 [doi]
Output Language
Unknown(0)
PMID
21961462
Abstract
BACKGROUND: The Food and Drug Administration currently is assessing the public health impact of menthol cigarettes. Whether menthol cigarettes pose increased barriers to quitting is a critical issue because previous declines in smoking prevalence have stalled. PURPOSE: To explore whether menthol cigarette smokers are less likely to quit than non-menthol smokers at the population level and whether this relationship differs by race/ethnicity. METHODS: Cross-sectional analyses of the 2003 and 2006/2007 Tobacco Use Supplement to the Current Population Survey were conducted in 2010. Multiple logistic regressions were used to calculate the adjusted odds of cessation for menthol smoking relative to non-menthol smoking. Five different sample restrictions were used to assess the robustness of the findings. RESULTS: In the broadest sample restriction, menthol smokers were less likely to have quit smoking (AOR=0.91, 95% CI=0.87, 0.96). This relationship holds among whites (AOR=0.93, 95% CI=0.88, 0.98) and blacks (AOR=0.81, 95% CI=0.67, 0.98). The magnitude of the relationship among Hispanics was similar to that among whites, but differed by Hispanic origin. Among those of Mexican origin, the AOR for menthol smokers was protective but not significant (AOR=1.29, 95% CI=0.99, 1.61), whereas among those of Puerto Rican origin, menthol smokers were less likely to have quit (AOR=0.57, 95% CI=0.37, 0.87). These findings were robust and significant in four of five sample restrictions. CONCLUSIONS: Smoking menthol cigarettes is associated with decreased cessation at the population level, and this association is more pronounced among black and Puerto Rican smokers. These findings support the recent calls to ban menthol flavoring in cigarettes.
Descriptors
Adolescent, Adult, Age Distribution, Aged, Cross-Sectional Studies, Ethnic Groups/statistics & numerical data, Flavoring Agents/administration & dosage, Humans, Logistic Models, Male, Menthol/administration & dosage, Middle Aged, Retrospective Studies, Self Report, Sex Distribution, Smoking/epidemiology/psychology, Smoking Cessation/ethnology/statistics & numerical data, Socioeconomic Factors, Tobacco/adverse effects/classification, Young Adult
Links
Book Title
Database
Publisher
American Journal of Preventive Medicine. Published by Elsevier Inc
Data Source
Authors
Delnevo,C. D., Gundersen,D. A., Hrywna,M., Echeverria,S. E., Steinberg,M. B.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Risk perceptions of menthol cigarettes compared with nonmenthol cigarettes among New Jersey adults 2010 Center for Tobacco Surveillance and Evaluation Research, School of Public Health, University of Medicine and Dentistry of New Jersey, 335 George Street, Suite 2100, New Brunswick, NJ 08903, USA. olivia.wackowski@umdnj.edu
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Jul
Volume
12
Issue
7
Start Page
786
Other Pages
790
Notes
LR: 20151119; JID: 9815751; 0 (Flavoring Agents); 1490-04-6 (Menthol); 2010/06/03 [aheadofprint]; ppublish
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 20522521
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1093/ntr/ntq085 [doi]
Output Language
Unknown(0)
PMID
20522521
Abstract
INTRODUCTION: Menthol cigarettes were historically marketed as "healthier" cigarettes, and menthol possesses cooling qualities that may reduce the perceived harshness of cigarette smoke. As such, it is possible that smokers may perceive menthol cigarettes to be safer when, in fact, some research suggests that menthols may be more addictive than regular cigarettes. Research shows that smokers have a faulty understanding of the risks of cigarettes in general, but little is known about smokers' risk perceptions for these particular products. METHODS: We examined data from the 2005 New Jersey Adult Tobacco Survey, a statewide random-digit-dial telephone survey monitoring tobacco-use behavior, knowledge, and attitudes and which asked participants to compare how risky (somewhat less risky, about the same, or somewhat more risky) menthol cigarettes were with nonmenthol cigarettes. RESULTS: Few menthol smokers (2.4%) and survey respondents overall (4.0%) believed menthol cigarettes to be less risky than nonmenthol cigarettes. In contrast, 30.2% of menthol smokers and 25.9% of all respondents (including nonsmokers) believed menthols to be more risky than nonmenthol cigarettes. Compared with never-smokers, nonmenthol smokers were most likely to believe this (AOR = 4.51), followed by former smokers (AOR = 1.77) and current menthol smokers (AOR = 1.58). Among current smokers, Blacks (AOR = 2.17) were more likely than Whites to indicate menthols as being more risky and young adults (18- to 24-year-olds) were the age group most likely to hold this belief (AOR = 3.30). CONCLUSIONS: Future research should explore whether these perceptions exist in broader population groups as well as their development and association with smoking-related behaviors.
Descriptors
Adult, Attitude to Health/ethnology, Behavior, Addictive/epidemiology/ethnology, Ethnic Groups/statistics & numerical data, Female, Flavoring Agents/administration & dosage, Humans, Male, Menthol/administration & dosage, Middle Aged, New Jersey/epidemiology, Smoking/epidemiology/ethnology, Smoking Cessation/ethnology, Social Perception, Surveys and Questionnaires, Tobacco Use Disorder/epidemiology, Young Adult
Links
Book Title
Database
Publisher
Data Source
Authors
Wackowski,O. A., Delnevo,C. D., Lewis,M. J.
Original/Translated Title
URL
Date of Electronic
20100603
PMCID
Editors
Young adults' behavioral intentions surrounding a potential menthol cigarette ban 2014 Center for Tobacco Surveillance and Evaluation Research, Rutgers School of Public Health, New Brunswick, NJ.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Jun
Volume
16
Issue
6
Start Page
876
Other Pages
880
Notes
LR: 20151209; GR: P30 CA072720/CA/NCI NIH HHS/United States; GR: P30CA072720/CA/NCI NIH HHS/United States; GR: R01 CA149705/CA/NCI NIH HHS/United States; GR: R01 CA149705-01/CA/NCI NIH HHS/United States; JID: 9815751; 1490-04-6 (Menthol); CIN: Nicotine To
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 24514070
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; IM
DOI
10.1093/ntr/ntu003 [doi]
Output Language
Unknown(0)
PMID
24514070
Abstract
INTRODUCTION: Menthol cigarette smoking is more prevalent among young adults, who are a known target of tobacco industry marketing. This study explores young adults' menthol use and behavioral intentions in the event of a ban on menthol cigarettes. METHODS: Data from 2,871 respondents of the 2011 National Young Adult Health Survey were examined to estimate young adults' current smoking, current menthol smoking, and behavioral intentions in the event of a menthol cigarette ban. RESULTS: Of all respondents, 23.8% were current smokers, and 40.3% of the current smokers were menthol smokers. Menthol use was significantly higher among 18- to 24-year-olds versus 25- to 34-year-olds (51% vs. 34.3%, p = .02) and was significantly associated with race/ethnicity (p
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Wackowski,O.A., Manderski,M.T., Delnevo,C.D.
Original/Translated Title
URL
Date of Electronic
20140210
PMCID
PMC4015098
Editors
E-Cigarette Market Trends in Traditional U.S. Retail Channels, 2012-2013 2015 Center for Tobacco Studies, Rutgers University-School of Public Health, New Brunswick, NJ; d.giovenco@rutgers.edu.; Department of Health Studies, University of Waterloo-School of Public Health and Health Systems, Waterloo, ON, Canada;; Center for Tobacco
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Oct
Volume
17
Issue
10
Start Page
1279
Other Pages
1283
Notes
LR: 20151223; CI: (c) The Author 2014; GR: HHSN271201100027C/PHS HHS/United States; JID: 9815751; 0 (Flavoring Agents); OID: NLM: PMC4683368 [Available on 10/01/16]; PMCR: 2016/10/01 00:00; 2014/09/04 [received]; 2014/12/11 [accepted]; 2014/12/26 [aheadof
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 25542918
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; IM
DOI
10.1093/ntr/ntu282 [doi]
Output Language
Unknown(0)
PMID
25542918
Abstract
INTRODUCTION: E-cigarette sales continue to increase in the United States. To date, little surveillance research has documented the specific product attributes driving growth. This study uses national market scanner data to describe sales trends in traditional U.S. tobacco retail channels between 2012 and 2013 and identifies product features associated with sales increases. METHODS: Data on e-cigarette sales in convenience stores, drug stores, grocery stores, and mass merchandisers in the United States were obtained from the Nielsen Company. Each product was coded for attributes such as brand, flavor, and unit size. Total sales volume, market share, and percent growth were calculated for various product attributes. RESULTS: E-cigarette sales more than doubled between 2012 and 2013, from $273.6 million to $636.2 million, respectively. Growth was particularly strong in the convenience store channel. Blu eCigs quickly emerged as the best-selling brand and in 2013 constituted nearly half (44.1%) of overall sales. Although fruit-flavored and other flavored products experienced marked growth, unflavored and menthol e-cigarettes overwhelmingly dominated the market. Sales of single unit products (likely disposable e-cigarettes) increased by 216.4%, a much faster rate than multi-unit packs and cartridge refills. CONCLUSIONS: In traditional U.S. retail channels, particularly the convenience store channel, sales of e-cigarettes continue to grow, with brands like blu and disposable products as the likely drivers. Given the rapidly-changing market, expanded surveillance is needed to monitor sales not only in traditional retail locations, but sales online and in specialty "vape shops," as well.
Descriptors
Links
Book Title
Database
Publisher
. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco
Data Source
Authors
Giovenco,D.P., Hammond,D., Corey,C.G., Ambrose,B.K., Delnevo,C.D.
Original/Translated Title
URL
Date of Electronic
20141226
PMCID
PMC4683368
Editors
Factors associated with e-cigarette use: a national population survey of current and former smokers 2014 Center for Tobacco Studies, Rutgers School of Public Health, Rutgers University, New Brunswick, New Jersey. Electronic address: d.giovenco@rutgers.edu.; Center for Tobacco Studies, Rutgers School of Public Health, Rutgers University, New Brunswick, New Je
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
American Journal of Preventive Medicine
Periodical, Abbrev.
Am.J.Prev.Med.
Pub Date Free Form
Oct
Volume
47
Issue
4
Start Page
476
Other Pages
480
Notes
LR: 20151001; CI: Copyright (c) 2014; GR: R21 CA155956/CA/NCI NIH HHS/United States; GR: R21 CA159160/CA/NCI NIH HHS/United States; GR: R21CA155956/CA/NCI NIH HHS/United States; GR: R21CA159160/CA/NCI NIH HHS/United States; JID: 8704773; NIHMS590650; OID:
Place of Publication
Netherlands
ISSN/ISBN
1873-2607; 0749-3797
Accession Number
PMID: 24880986
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; IM
DOI
10.1016/j.amepre.2014.04.009 [doi]
Output Language
Unknown(0)
PMID
24880986
Abstract
BACKGROUND: Few national surveys document the prevalence of e-cigarette use in the U.S. The existing metric to assess current use likely identifies individuals who have recently tried an e-cigarette but do not continue to use the product. PURPOSE: To document the prevalence of e-cigarette ever use, current use, and established use in a nationally representative survey of current and former cigarette smokers in the U.S. METHODS: A random sample of current and former cigarette smokers completed a web-based survey in June 2013 (n=2,136). Data were analyzed in November 2013. Multivariate logistic regression identified demographic and smoking-related factors associated with each use category. Point estimates with 95% CIs described e-cigarette use behaviors (e.g., preferred brand, purchasing patterns) for each group. RESULTS: Almost half of respondents had tried e-cigarettes (46.8%), but prevalence of established use remained low (3.8%). Although trial of e-cigarettes was highest among daily smokers, the odds of being an established e-cigarette user were greater for former smokers (OR=3.24, 95% CI=1.13, 9.30, p
Descriptors
Links
Book Title
Database
Publisher
American Journal of Preventive Medicine. Published by Elsevier Inc
Data Source
Authors
Giovenco,D.P., Lewis,M.J., Delnevo,C.D.
Original/Translated Title
URL
Date of Electronic
20140528
PMCID
PMC4214213
Editors
The influence of menthol, e-cigarettes and other tobacco products on young adults' self-reported changes in past year smoking 2016 Center for Tobacco Studies, Rutgers School of Public Health, New Brunswick, New Jersey, USA Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; The Schroeder Institute for Tobacco Research and Policy Studies, American Legacy Foundatio
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Tobacco control
Periodical, Abbrev.
Tob.Control
Pub Date Free Form
Sep
Volume
25
Issue
5
Start Page
571
Other Pages
574
Notes
LR: 20160822; CI: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/; GR: R01 CA149705/CA/NCI NIH HHS/United Stat
Place of Publication
England
ISSN/ISBN
1468-3318; 0964-4563
Accession Number
PMID: 26243809
Language
eng
SubFile
Journal Article; IM
DOI
10.1136/tobaccocontrol-2015-052325 [doi]
Output Language
Unknown(0)
PMID
26243809
Abstract
OBJECTIVE: Progression to regular smoking often occurs during young adulthood. This study examines self-reported changes in past year smoking among young adults and the potential influence of tobacco products on these trajectories. METHODS: Respondents to the 2011 National Young Adult Health Survey who smoked 100 cigarettes in their lifetime (n=909) described smoking behaviour at the time of the survey and 1 year prior. Cigarette smoking trajectories were categorised as: no change, quit, decreased smoking or increased smoking. Participants were also asked about current use of menthol cigarettes and other tobacco products (ie, cigars, smokeless tobacco, hookah) and ever use of e-cigarettes. RESULTS: Most young adults (73.1%) reported stable cigarette smoking behaviours, while 8.2% reported having quit, 5.8% reported that they smoke on fewer days, 5% progressed from someday to daily smoking and 8% increased from not at all to current smoking. The youngest smokers (18-20) had significantly higher odds (adjusted OR (AOR) =2.6) of increasing cigarette use over the past year compared to those aged 30-34, as did blacks versus whites (AOR=2.35). Menthol cigarette use nearly doubled (AOR=1.87) the odds of increased smoking behaviour. E-cigarette and other tobacco product (OTP) use were not associated with increasing smoking but OTP use was negatively associated with remaining quit from cigarettes. CONCLUSIONS: Young adulthood is a critical period for smoking interventions, particularly among those most vulnerable to increasing smoking behaviours (ie, black and younger young adults). Policy efforts to restrict menthol cigarettes may reduce young adult smoking progression.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Delnevo,C.D., Villanti,A.C., Wackowski,O.A., Gundersen,D.A., Giovenco,D.P.
Original/Translated Title
URL
Date of Electronic
20150804
PMCID
PMC4740271
Editors
Varying nicotine patch dose and type of smoking cessation counseling 1995 Center for Tobacco Research and Intervention, University of Wisconsin-Madison, USA.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Jama
Periodical, Abbrev.
JAMA
Pub Date Free Form
1-Nov
Volume
274
Issue
17
Start Page
1347
Other Pages
1352
Notes
LR: 20151119; JID: 7501160; 6M3C89ZY6R (Nicotine); 7U1EE4V452 (Carbon Monoxide); K5161X06LL (Cotinine); CIN: JAMA. 1996 Jun 26;275(24):1882-3. PMID: 8648863; CIN: JAMA. 1995 Nov 1;274(17):1390-1. PMID: 7563566; ppublish
Place of Publication
UNITED STATES
ISSN/ISBN
0098-7484; 0098-7484
Accession Number
PMID: 7563558
Language
eng
SubFile
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; AIM; IM
DOI
Output Language
Unknown(0)
PMID
7563558
Abstract
OBJECTIVE: To compare the efficacy and safety of 22-mg and 44-mg doses of transdermal nicotine therapy when it is paired with minimal, individual, or group counseling to improve smoking cessation rates. DESIGN: An 8-week clinical trial (4 weeks double-blind followed by 4 weeks open label) using random assignment of participants to both dose (22 or 44 mg) and counseling (minimal, individual, or group) conditions. PARTICIPANTS: Daily cigarette smokers (> or = 15 cigarettes per day for at least 1 year) who volunteered to participate in a study of smoking cessation treatment. A total of 504 participants were enrolled at two sites. INTERVENTION: Four weeks of 22- or 44-mg transdermal nicotine therapy followed by 4 weeks of dosage reduction (2 weeks of 22 mg followed by 2 weeks of 11 mg). Counseling consisted of a self-help pamphlet (minimal); a self-help pamphlet, a brief physician motivational message, and three brief (< 15 minutes) follow-up visits with a nurse (individual); or the pamphlet, the motivational message, and eight weekly 1-hour group smoking cessation counseling visits (group). All participants returned weekly to turn in questionnaires and for assessment of their smoking status. MAIN OUTCOME MEASURES: Abstinence from smoking was based on self-report, confirmed by an expired carbon monoxide concentration lower than 10 ppm. Withdrawal severity was assessed by means of an eight-item self-report questionnaire completed daily. RESULTS: Smoking cessation rates for the two nicotine patch doses and three levels of counseling did not differ significantly at either 8 weeks or 26 weeks following the quit date. Among those receiving minimal contact, the 44-mg dose produced greater abstinence at 4 weeks than did the 22-mg dose (68% vs 45%; P < .01). Participants receiving minimal-contact adjuvant treatment were less likely to be abstinent at the end of 4 weeks than those receiving individual or group counseling (56% vs 67%; P < .05). The 44-mg dose decreased desire to smoke more than the 22-mg dose, but this effect was not related to success in quitting smoking. Transdermal nicotine therapy at doses of 44 mg produced a significantly greater frequency of nausea (28%), vomiting (10%), and erythema with edema at the patch site (30%) than did a 22-mg dose (10%, 2%, and 13%, respectively; P < .01 for each adverse effect). Three serious adverse events occurred during use of the 44-mg patch dose. CONCLUSIONS: There does not appear to be any general, sustained benefit of initiating transdermal nicotine therapy with a 44-mg patch dose or of providing intense adjuvant smoking cessation treatment. The two doses and all adjuvant treatments produced equivalent effects at the 26-week follow-up, and the higher patch dose produced more adverse effects. Higher-dose (44-mg) nicotine replacement does not appear to be indicated for general clinical populations, although it may provide short-term benefit to some smokers attempting to quit with minimal adjuvant treatment.
Descriptors
Administration, Cutaneous, Adult, Analysis of Variance, Carbon Monoxide/metabolism, Combined Modality Therapy, Cotinine/blood, Counseling, Double-Blind Method, Female, Humans, Logistic Models, Male, Middle Aged, Nicotine/administration & dosage/therapeutic use, Smoking Cessation/methods, Substance Withdrawal Syndrome
Links
Book Title
Database
Publisher
Data Source
Authors
Jorenby,D. E., Smith,S. S., Fiore,M. C., Hurt,R. D., Offord,K. P., Croghan,I. T., Hays,J. T., Lewis,S. F., Baker,T. B.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment 2011 Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI 53711, USA. mep@ctri.medicine.wisc.edu
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Addiction (Abingdon, England)
Periodical, Abbrev.
Addiction
Pub Date Free Form
Feb
Volume
106
Issue
2
Start Page
418
Other Pages
427
Notes
LR: 20151119; CI: (c) 2010 The Authors, Addiction (c) 2010; GR: 1K05CA139871/CA/NCI NIH HHS/United States; GR: 1KL2RR025012-01/RR/NCRR NIH HHS/United States; GR: K05 CA139871/CA/NCI NIH HHS/United States; GR: K05 CA139871-04/CA/NCI NIH HHS/United States;
Place of Publication
England
ISSN/ISBN
1360-0443; 0965-2140
Accession Number
PMID: 20973856
Language
eng
SubFile
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; IM
DOI
10.1111/j.1360-0443.2010.03173.x [doi]
Output Language
Unknown(0)
PMID
20973856
Abstract
AIMS: To understand the relations among anxiety disorders and tobacco dependence, withdrawal symptoms, response to smoking cessation pharmacotherapy and ability to quit smoking. DESIGN: Randomized placebo-controlled clinical trial. Participants received six 10-minute individual counseling sessions and either: placebo, bupropion SR, nicotine patch, nicotine lozenge, bupropion SR + nicotine lozenge or nicotine patch + nicotine lozenge. SETTING: Two urban research sites. PARTICIPANTS: Data were collected from 1504 daily smokers (>9 cigarettes per day) who were motivated to quit smoking and did not report current diagnoses of schizophrenia or psychosis or bupropion use. MEASUREMENTS: Participants completed baseline assessments, the Composite International Diagnostic Interview and ecological momentary assessments for 2 weeks. FINDINGS: A structured clinical interview identified participants who ever met criteria for a panic attack (n = 455), social anxiety (n = 199) or generalized anxiety disorder (n = 99), and those who qualified for no anxiety diagnosis (n = 891). Smokers with anxiety disorders reported higher levels of nicotine dependence and pre-quit withdrawal symptoms. Those ever meeting criteria for panic attacks or social anxiety disorder showed greater quit-day negative affect. Smokers ever meeting criteria for anxiety disorders were less likely to be abstinent at 8 weeks and 6 months post-quit and showed no benefit from single-agent or combination-agent pharmacotherapies. CONCLUSIONS: Anxiety diagnoses were common among treatment-seeking smokers and were related to increased motivation to smoke, elevated withdrawal, lack of response to pharmacotherapy and impaired ability to quit smoking. These findings could guide treatment assignment algorithms and treatment development for smokers with anxiety diagnoses.
Descriptors
Links
Book Title
Database
Publisher
Society for the Study of Addiction
Data Source
Authors
Piper,M.E., Cook,J.W., Schlam,T.R., Jorenby,D.E., Baker,T.B.
Original/Translated Title
URL
Date of Electronic
20101025
PMCID
PMC3017215
Editors
Predicting smoking cessation. Who will quit with and without the nicotine patch 1994 Center for Tobacco Research and Intervention, University of Wisconsin Medical School, Madison 53706-1532.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Jama
Periodical, Abbrev.
JAMA
Pub Date Free Form
23-Feb
Volume
271
Issue
8
Start Page
589
Other Pages
594
Notes
LR: 20151119; JID: 7501160; 6M3C89ZY6R (Nicotine); 7U1EE4V452 (Carbon Monoxide); K5161X06LL (Cotinine); ppublish
Place of Publication
UNITED STATES
ISSN/ISBN
0098-7484; 0098-7484
Accession Number
PMID: 8301790
Language
eng
SubFile
Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; AIM; IM
DOI
Output Language
Unknown(0)
PMID
8301790
Abstract
OBJECTIVE: To identify predictors of smoking cessation success or failure with and without transdermal nicotine patch treatment. DESIGN: Two independent randomized, double-blind, placebo-controlled studies using the nicotine patch assessing outcome at the end of treatment and at 6-month follow-up; each study used a different mode of adjuvant counseling. PATIENTS: Subjects were daily smokers (> or = 15 cigarettes per day), aged 21 to 65 years with expired air carbon monoxide levels of at least 10 ppm, and motivated to quit. Eighty-eight subjects participated in study 1, and 112 subjects participated in study 2. INTERVENTION: Study 1 consisted of 8 weeks of 22-mg nicotine patch therapy with intensive group counseling. Study 2 consisted of 4 weeks of 22-mg nicotine patch therapy and 2 weeks of 11-mg nicotine patch therapy with brief individual counseling. MAIN OUTCOME MEASURES: The prediction of smoking cessation (at end of treatment and after 6 months) based on pretreatment and intratreatment measures in smokers using active or placebo nicotine patches. RESULTS: Pretreatment markers, such as the Fagerstrom Tolerance Questionnaire score, number of cigarettes smoked per day, years smoked, expired air carbon monoxide level, or baseline blood nicotine and cotinine levels, showed no consistent relationship with successful smoking cessation across both studies. Of the intratreatment markers examined, withdrawal severity and nicotine replacement levels also were not consistently predictive of cessation success. However, any smoking during the second week of treatment was a consistent and powerful predictor of failure at the end of treatment and after 6 months. Among active nicotine patch patients who smoked at all during week 2 after quitting, 83% and 97% (studies 1 and 2, respectively) were smoking at 6-month follow-up. Conversely, abstinence during the second week of treatment predicted successful smoking cessation. Among active nicotine patch patients who were totally abstinent during week 2 after quitting, 46% and 41% (studies 1 and 2, respectively) were abstinent at 6-month follow-up. Of all nicotine patch patients in both studies who were smoking at 6-month follow-up, 74% began smoking during week 1 or 2. Among all placebo patch patients who were smoking at 6-month follow-up, 86% began smoking during week 1 or 2. CONCLUSIONS: Smoking status (abstinent or smoking) during the first 2 weeks of nicotine patch therapy, particularly week 2, was highly correlated with clinical outcome and can serve as a powerful predictor of smoking cessation. Early smoking behavior also predicted outcome among placebo patch users. Traditional measures of dependence are not consistently predictive of cessation success. Clinicians are advised to emphasize the importance of total abstinence after a quit attempt and to follow-up with patients within the first 2 weeks of quitting; smoking during this critical time should be assessed and treatment may be altered as appropriate.
Descriptors
Administration, Cutaneous, Adult, Aged, Breath Tests, Carbon Monoxide/analysis, Confidence Intervals, Cotinine/blood, Counseling, Double-Blind Method, Female, Follow-Up Studies, Humans, Logistic Models, Male, Middle Aged, Nicotine/administration & dosage/blood, Odds Ratio, Smoking/therapy, Smoking Cessation/methods/statistics & numerical data, Treatment Outcome
Links
Book Title
Database
Publisher
Data Source
Authors
Kenford,S. L., Fiore,M. C., Jorenby,D. E., Smith,S. S., Wetter,D., Baker,T. B.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Nicotine dependence among Chinese city dwellers: a population-based cross-sectional study 2011 Center for Tobacco Control Research, Zhejiang University School of Medicine, Yuhangtang Road, Hangzhou, Zhejiang, China. ytingzhongyang@yahoo.com
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Jul
Volume
13
Issue
7
Start Page
556
Other Pages
564
Notes
LR: 20151119; JID: 9815751; 2011/03/31 [aheadofprint]; ppublish
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 21454911
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1093/ntr/ntr040 [doi]
Output Language
Unknown(0)
PMID
21454911
Abstract
INTRODUCTION: Although nicotine addiction is thought to be the primary driver of tobacco smoking, few studies have examined nicotine dependence among Chinese mainland smokers. METHODS: A population-based cross-sectional study was designed. Subjects (4735) aged 15 years and older residents were drawn from six cities in China through a multistage systematic sampling procedure. Nicotine dependence of respondents was assessed in a face-to-face interview using the 6-item Mandarin Chinese version of the Fagerstrom Test for Nicotine Dependence (FTND). A multilevel regression model, accounting for cluster sampling, was used to identify correlates of dependence. RESULTS: Among females, only 4.2% (n = 115) were smokers (2.5% daily, 1.7% occasional). Subsequent analysis focused on males, of whom 50.8% (n = 1477) were smokers (38.9% daily, 11.9% occasional). The average FTND score was 2.89 (95% CI: 2.77-3.01) among all current smokers. Daily smokers had a significantly higher FTND score (3.49, 95% CI: 3.35-3.63) than occasional smokers (1.12, 95% CI: 0.98-1.26) (p /= 4. Among daily smokers, FTND scores were negatively associated with age at smoking initiation, education, and self-efficacy for quitting smoking. FTND was associated (negatively) with income among occasional smokers only. There were regional differences in FTND scores among daily smokers. CONCLUSIONS: Cigarette smoking is highly prevalent among Chinese males but rare among Chinese females. Occasional smoking is also common among males. Only 3.3% of occasional male smokers appear dependent by FTND criteria. Dependence varies by smoking history and demographics. These findings have implications for design and implementation of smoking cessation interventions.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Yang,T., Shiffman,S., Rockett,I.R., Cui,X., Cao,R.
Original/Translated Title
URL
Date of Electronic
20110331
PMCID
Editors